Tropicamide

CAS 1508-75-4 5 current records 4 historicalSmall Molecule

Who holds supplier records for Tropicamide? 5 organisations hold a current record for Tropicamide: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), United States (1) and Spain (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tropicamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tropicamide

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tropicamide. Country is the organisation's recorded country, not necessarily the manufacturing site.

India2United States1Spain1Country not recorded for 1
Need Tropicamide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Tropicamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
BIOXERA PHARMA PRIVATE LIMITED ThaneIN
CEP 2025-144 - Rev 00
Tropicamide
Sept 2026Inspected Dec 2024
Switzerland
DISHMAN CARBOGEN AMCIS LIMITED AhmedabadIN
CEP 1998-077 - Rev 11
Tropicamide
Aug 2024—
C-SQUARED PHARMA LIMITED CorkIE
CEP 2022-500 - Rev 01
Tropicamide
Jul 2024—
Tokyo Chemical Industry Co. Ltd (TCI) TokyoJP
R1-CEP 1999-126 - Rev 02
Tropicamide
Feb 2011—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Tropicamide are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • SHIONO FINESSE LTD
    Inactive DMF 14940 · filed Jul 2000
  • OKAMI CHEMICAL INDUSTRY CO LTD
    Inactive DMF 14743 · filed Feb 2000
  • Switzerland · Inactive DMF 12596 · filed Jul 1997
  • AMCIS AG
    Inactive DMF 6006 · filed Sept 1985

Overview

Tropicamide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200604).

Chemical identity

IUPAC name
N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide
Canonical SMILES
CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2
InChIKey
BGDKAVGWHJFAGW-UHFFFAOYSA-N
Synonyms
Bistropamide, Mydriacyl, Mydriafair, Nods, NSC-757372, RO-1-7683, Tropicacyl, Tropicamida, Tropicamide, Tropicamide component of mydcombi, Tropicamide component of paremyd, Tropicamidum

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anticholinergic
Mechanism of action
Cholinergic Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tropicamide?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Tropicamide: TOKYO CHEMICAL INDUSTRY CO LTD, C-SQUARED PHARMA LTD (United States), UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (Spain), Dishman Carbogen Amcis Limited (India) and BIOXERA PHARMA PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tropicamide Drug Master Files are active?

TOKYO CHEMICAL INDUSTRY CO LTD (DMF 10981), C-SQUARED PHARMA LTD (DMF 37987) and UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (DMF 17800). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Tropicamide records mean?

4 organisations have only inactive Type II DMFs for Tropicamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Tropicamide have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Tropicamide on the EDQM register, including BIOXERA PHARMA PRIVATE LIMITED Thane (IN), DISHMAN CARBOGEN AMCIS LIMITED Ahmedabad (IN), C-SQUARED PHARMA LIMITED Cork (IE) and Tokyo Chemical Industry Co. Ltd (TCI) Tokyo (JP). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tropicamide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tropicamide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.